Loading...
Market
Public sentiment towards Pfizer post-Zantac settlement
2
Resolution / Starting Odds
Significantly worsens • 25%
Worsens • 25%
No significant change • 25%
Improves • 25%
Reputed consumer survey reports
Story
Pfizer to Pay $250 Million to Settle Over 10,000 Zantac Cancer Lawsuits
May 16, 2024, 04:55 AM
Pfizer has agreed to offer up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac. The Financial Times reported this settlement on Thursday.
View original story
Similar markets
No similar markets found.